1-877-937-7478
Yttrium 90 Microspheres Education and Support
When The Improbable
Is Possible
YES was founded by three colon cancer survivors and two caregivers in 2006 – Gordon Gwosdow, Suzanne Lindley, Cheri Simmons, Todd Mozingo, and Dr. Jim Varner. Each having received either SIR-Spheres or Therasphere or hoping for their loved ones to benefit from it, they were discouraged by the lack of information and resources available to those affected by liver metastases and concerned about the under-representation of survivors who had received treatment with Yttrium 90 Microspheres. Realizing the need for survivor support and a desire to share information, YES was created.
YES seeks to change the face of primary hepatocellular carcinoma or liver metastases by: advocating for continued coverage of brachytherapy procedures and increased funding for cancer research, educating liver tumor survivors of possible treatment options with Yttrium 90 Microspheres, and by being a point of contact and support for those affected by liver tumors.
“There is nothing more we can do” is a refrain we hear frequently,” says Gordon Gwosdow, eight year stage IV colon cancer survivor and co-founder of YES. “Yet, here we are, right in front of the medical and research communities representing the global voice of all survivors living with liver tumors. If these survivors had access to treatment options readily available they may unlock the key to longer survival and begin to live with this as a chronic condition and not as a deadly disease.”
Today, YES is a growing international group of hundreds of survivors and supporters. Embracing the mottos, “Making the Improbable Possible” members participate in an online list-serv, attend tele-conferences, lobby federal and state legislators, speak at conferences and health fairs, and will soon begin an annual awareness campaign targeted at the medical community – encouraging doctors and researchers to focus more resources on this underserved segment of the population. YES strives to educate and support all survivors living with a diagnosis of liver tumors.
